Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | 15002134094 |
| E-mail: | marketing@targetmol.cn |
| QQ: | 2881954871 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Umbralisib tosylate | C38H32F3N5O6S | 1532533-72-4 | Details |
| EFdA-TP tetrasodium | 2883783-00-2 | Details |
| 3-Oxo-hop-22(29)-ene | C30H48O | 25615-11-6 | Details |
| Anticancer agent 25 | C37H45N2O3.Br | 2401013-08-7 | Details |
| Anticancer agent 99 | C19H20F3N3O2 | 2914922-83-9 | Details |
| ERK-IN-2 free base | C16H17N5O2 | 2743576-55-6 | Details |
| GnRH-R antagonist 1 | C31H28F5N7O6S | 2826273-90-7 | Details |
| Niclosamide sodium | C13H9Cl2N2NaO4 | 40321-86-6 | Details |
| IACS-8779 disodium | C21H26N9NaO10P2S2 | 2243079-27-6 | Details |
| NOD1/2 antagonist-1 | C32H28ClF5N4O4 | 2704623-69-6 | Details |
| Aurora Kinases-IN-3 | C20H16F3N3O4 | 2840558-83-8 | Details |
| Anticancer agent 53 | C31H25FN4O6S | 1926985-18-3 | Details |
| Sirtuin modulator 4 | C18H10N2O2S | 327104-77-8 | Details |
| Palmatine hydroxide | C21H22NO4.HO | 131-04-4 | Details |
| Anticancer agent 66 | C26H23Cl2FN6O2S2 | 2691895-64-2 | Details |
| Antioxidant agent-2 | C23H26N2O7 | 2250106-92-2 | Details |
| Umbralisib sulfate | C31H26F3N5O7S | 1532533-75-7 | Details |
| Aliskiren fumarate | C34H57N3O10 | 1196835-68-3 | Details |
| 6-Fluoromevalonate | C6H9FO3 | 2822-77-7 | Details |
| HIV-1 inhibitor-10 | C39H54O6 | 1449660-81-4 | Details |
| Plm IV inhibitor-2 | C39H54N4O4 | 1539276-38-4 | Details |
| Antitumor agent-87 | C22H28N2O6S | 1422527-88-5 | Details |
| GPR84 antagonist 2 | C28H18Cl2NaO4PS2 | 2244269-74-5 | Details |
| IL-17A modulator-3 | C34H50FN7O4 | 2467732-95-0 | Details |
| 4-Formylcolchicine | C23H25NO7 | 2730-82-7 | Details |
| Transketolase-IN-2 | C18H9F3N2O3S | 2757552-21-7 | Details |
| Antitumor agent-81 | C19H19N7O3 | 2765180-17-2 | Details |
| Antitumor agent-88 | C23H30N2O7S | 1422527-87-4 | Details |
| Tubulin inhibitor 30 | C22H19N3O5 | 2873383-67-4 | Details |
| Influenza virus-IN-6 | C27H26ClNO7 | 2919303-26-5 | Details |
| Calpain Inhibitor XI | C19H29N3O4 | 145731-49-3 | Details |
| Thrombin inhibitor 6 | C18H19ClN4O2S | 1628224-94-1 | Details |
| SARS-CoV-2 Mpro-IN-6 | C18H18Cl3N3O2S | 2768834-48-4 | Details |
| SARS-CoV-2 3CLpro-IN-5 | C22H26ClF2N5O4 | 2913186-57-7 | Details |
| SARS-CoV-2 3CLpro-IN-7 | C24H17ClN2O6 | 1164478-67-4 | Details |
| Neuroinflammatory-IN-3 | C19H19ClO3 | 1202404-23-6 | Details |
| PI3K/mTOR Inhibitor-12 | C27H27F2N9O4S | 2891692-83-2 | Details |
| PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
| Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| Crozbaciclib fumarate | C32H34F2N6O4 | 2567494-39-5 | Details |
| KRAS G12D inhibitor 3 | C34H31ClF3N5O2 | 2757095-11-5 | Details |
| Antimalarial agent 20 | C31H38N4O3 | 1422207-75-7 | Details |
| CB1 inverse agonist 2 | C24H20ClFN2OS | 1019839-52-1 | Details |
| Sortilin antagonist 1 | C20H24N2O4 | 2691846-93-0 | Details |
| 5-Cyclopropylpentanal | C8H14O | 147159-38-4 | Details |
| PI3K/mTOR Inhibitor-5 | C32H40N10O3 | 2456295-60-4 | Details |
| AChE/Nrf2 modulator 1 | C27H27FN4O2 | 2417117-84-9 | Details |
| Endomorphin 1 acetate | C36H42N6O7 | 1276123-71-7 | Details |
| Ferroptosis inducer-1 | C25H21ClN2O5 | 2375357-96-1 | Details |
| PARP11 inhibitor ITK7 | C17H14N4OS | 2411890-36-1 | Details |
| LIMK1 inhibitor BMS-4 | C23H23N7O2S | 905298-84-2 | Details |
| SARS-CoV MPro-IN-2 | C13H10O4 | 81418-42-0 | Details |
| Lapatinib tosylate | C36H34ClFN4O7S2 | 1187538-35-7 | Details |
| Dihydroaltenuene B | C15H18O6 | 887751-89-5 | Details |
| HIV-1 inhibitor-53 | C30H34N2O8S | 2883496-10-2 | Details |
| HIV-1 inhibitor-52 | C46H72FNO5S | 1818868-23-3 | Details |
| Isoandrographolide | C20H30O5 | 4176-96-9 | Details |
| Kallikrein 5-IN-2 | C23H22N6O | 2361160-57-6 | Details |
| Lck Inhibitor III | C25H30N6O4 | 1188890-30-3 | Details |
| Broussochalcone A | C20H20O5 | 99217-68-2 | Details |
| STING modulator-4 | C17H18N8O | 2839639-72-2 | Details |
| Mcl-1 inhibitor 9 | C32H39ClN2O5S | 1883727-31-8 | Details |
| c-Myc inhibitor 8 | C19H12BrClF3NO3S2 | 2173505-97-8 | Details |
| LTB4 antagonist 1 | C26H23NO6 | 2929239-84-7 | Details |
| IL-17 modulator 5 | C28H23F6N9O2 | 2724206-27-1 | Details |
| AT1R antagonist 1 | C28H32F3N5O4S2 | 2848719-80-0 | Details |
| Multi-kinase-IN-1 | C35H36F2N6O6S | 2470807-67-9 | Details |
| A3AR antagonist 2 | C22H16N6O3 | 1144161-05-6 | Details |
| STING modulator-3 | C18H17N9O | 2839639-94-8 | Details |
| GLP-1R agonist 17 | C28H26ClFN4O4S | 2749609-28-5 | Details |
| RORγt inhibitor 2 | C31H33F5N2O7S | 2673278-10-7 | Details |
| c-Myc inhibitor 9 | C27H31N5OS | 2799717-96-5 | Details |
| GCGR antagonist 2 | C28H26N4O2 | 280134-25-0 | Details |
| IRE1α kinase-IN-7 | C28H25F3N6O | 1414938-22-9 | Details |
| Z-LE(OMe)TD(OMe)-FMK | C30H43FN4O11 | 210344-93-7 | Details |
| CBB1007 hydrochloride (1379573-92-8 free base) | C27H34N8O4.5ClH | 2070014-96-7 | Details |
| A2AR-antagonist-1 | C27H25N5O2 | 2922920-71-4 | Details |
| URAT1 inhibitor 4 | C27H20BrN3O4S3 | 2700292-02-8 | Details |
| A1AT modulator 2 | C27H22FN3O3 | 2555004-05-0 | Details |
| Cefepime chloride | C19H25ClN6O5S2 | 107648-79-3 | Details |
| (R)-PD 0325901CL | C16H14ClF2IN2O4 | 1003216-77-0 | Details |
| PD-1/PD-L1-IN-26 | C43H52N4O8 | 2966090-78-6 | Details |
| SARS-CoV-2-IN-12 | C30H41N5O7.C2HF3O2 | 2721455-52-1 | Details |
| (R)-Elsubrutinib | C17H19N3O2 | 1643570-23-3 | Details |
| BTK inhibitor 20 | C37H42N8O4 | 2696450-27-6 | Details |
| iNOS inhibitor-10 | C22H23N3O2S | 2918773-63-2 | Details |
| SIRT5 inhibitor 5 | C21H14ClN3O3S | 2883730-60-5 | Details |
| Axl/Mer/CSF1R-IN-1 | C25H24F3N5O5 | 2394874-60-1 | Details |
| PfGSK3/PfPK6-IN-2 | C24H25Cl2N5OS | 2797225-47-7 | Details |
| RORγt modulator 5 | C27H22F5N3O6S | 2119042-65-6 | Details |
| HIV-1 inhibitor-50 | C24H18FN5O2 | 2834087-69-1 | Details |
| LRRK2/NUAK1/TYK2-IN-1 | C20H11F3N6 | 2629192-96-5 | Details |
| (S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
| SARS-CoV-2 3CLpro-IN-6 | C22H15NO7 | 302821-53-0 | Details |
| Anticancer agent 100 | C18H20ClN3O | 2914922-73-7 | Details |
| GR 89696 free base | C19H25Cl2N3O3 | 126766-31-2 | Details |
| Efflux inhibitor-1 | C28H25N5O3 | 1776055-29-8 | Details |
| MRS2279 diammonium | C13H21ClN6O8P2 | 2387505-47-5 | Details |
| Antiviral agent 23 | C18H21N5O4 | 35940-03-5 | Details |
| Product Total： Product Page： | ||||
| 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | ||||